Metropolitan Life Insurance Company (MetLife)’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,921
Closed -$267K 2396
2022
Q3
$267K Hold
3,921
0.01% 586
2022
Q2
$125K Hold
3,921
0.01% 930
2022
Q1
$136K Sell
3,921
-12,697
-76% -$440K ﹤0.01% 1012
2021
Q4
$486K Hold
16,618
0.01% 1451
2021
Q3
$423K Hold
16,618
0.01% 1572
2021
Q2
$582K Buy
16,618
+12,305
+285% +$431K 0.01% 1421
2021
Q1
$176K Sell
4,313
-195
-4% -$7.95K ﹤0.01% 2112
2020
Q4
$195K Sell
4,508
-24
-0.5% -$1.04K ﹤0.01% 1955
2020
Q3
$250K Sell
4,532
-117
-3% -$6.45K ﹤0.01% 1646
2020
Q2
$293K Sell
4,649
-12,990
-74% -$820K 0.01% 1559
2020
Q1
$901K Buy
17,639
+215
+1% +$11K 0.02% 733
2019
Q4
$1.39M Sell
17,424
-539
-3% -$42.8K 0.02% 730
2019
Q3
$872K Buy
17,963
+807
+5% +$39.2K 0.01% 931
2019
Q2
$902K Buy
17,156
+283
+2% +$14.9K 0.02% 953
2019
Q1
$893K Buy
16,873
+562
+3% +$29.7K 0.02% 945
2018
Q4
$670K Hold
16,311
0.01% 1027
2018
Q3
$620K Hold
16,311
0.01% 1219
2018
Q2
$737K Buy
16,311
+4,030
+33% +$182K 0.01% 1082
2018
Q1
$593K Buy
12,281
+215
+2% +$10.4K 0.01% 1167
2017
Q4
$475K Sell
12,066
-13,426
-53% -$529K 0.01% 1322
2017
Q3
$792K Hold
25,492
0.01% 1391
2017
Q2
$697K Buy
25,492
+13,957
+121% +$382K ﹤0.01% 1460
2017
Q1
$425K Hold
11,535
﹤0.01% 1760
2016
Q4
$167K Hold
11,535
﹤0.01% 2458
2016
Q3
$266K Hold
11,535
﹤0.01% 2148
2016
Q2
$191K Buy
+11,535
New +$191K ﹤0.01% 2346
2016
Q1
Sell
-7,158
Closed -$231K 2538
2015
Q4
$231K Buy
+7,158
New +$231K ﹤0.01% 2155